Pre-conception maternal erythrocyte saturated to unsaturated fatty acid ratio predicts pregnancy after natural cycle frozen embryo transfer
|
|
- Flora Myrtle Green
- 5 years ago
- Views:
Transcription
1 University of Wollongong Research Online Faculty of Science, Medicine and Health - Papers Faculty of Science, Medicine and Health 2018 Pre-conception maternal erythrocyte saturated to unsaturated fatty acid ratio predicts pregnancy after natural cycle frozen embryo transfer Christopher C. Onyiaodike University of Glasgow Heather Murray University of Glasgow Ruiqi Zhang University of Glasgow Barbara J. Meyer University of Wollongong, bmeyer@uow.edu.au Fiona Jordan University of Glasgow See next page for additional authors Publication Details Onyiaodike, C. C., Murray, H. M., Zhang, R., Meyer, B. J., Jordan, F., Brown, E. Ann., Nibbs, R. J. B., Lyall, H., Sattar, N., Nelson, S. M. & Freeman, D. J. (2018). Pre-conception maternal erythrocyte saturated to unsaturated fatty acid ratio predicts pregnancy after natural cycle frozen embryo transfer. Scientific Reports, 8 (1), Research Online is the open access institutional repository for the University of Wollongong. For further information contact the UOW Library: research-pubs@uow.edu.au
2 Pre-conception maternal erythrocyte saturated to unsaturated fatty acid ratio predicts pregnancy after natural cycle frozen embryo transfer Abstract The environment for embryo implantation and fetal growth and development is affected by matern al nutritional, metabolic and health status. The aim of this prospective, cohort study was to test whether plasma metabolic and inflammatory biomarkers can predict pregnancy resulting from in vitro fertilisation (IVF). Women with a natural menstrual cycle undergoing frozen embryo transfer (FET) were recruited and fasting baseline blood samples were collected a mean of 3.4 days prior to the luteinising hormone (LH) surge and a non-fasting blood sample was taken on the day of FET. Ongoing pregnancy was defined by positive fetal heartbeat on ultrasound scan at day 45 post LH surge. Thirty-six pregnancies resulted from FET in 143 women. In an overall stepwise multivariable analysis, erythrocyte saturated to unsaturated fatty acid ratio was positively associated with ongoing pregnancy. A similar model incorporating day of FET covariates found that erythrocyte saturated to unsaturated fatty acid ratio, erythrocyte fatty acid average chain length and plasma log-triglycerides predicted ongoing pregnancy. In conclusion, a higher peri-conceptional saturated to unsaturated fatty acid ratio predicted ongoing pregnancy after natural cycle frozen embryo transfer and may reflect a maternal nutritional status that facilitates pregnancy success in this assisted conception scenario. Disciplines Medicine and Health Sciences Social and Behavioral Sciences Publication Details Onyiaodike, C. C., Murray, H. M., Zhang, R., Meyer, B. J., Jordan, F., Brown, E. Ann., Nibbs, R. J. B., Lyall, H., Sattar, N., Nelson, S. M. & Freeman, D. J. (2018). Pre-conception maternal erythrocyte saturated to unsaturated fatty acid ratio predicts pregnancy after natural cycle frozen embryo transfer. Scientific Reports, 8 (1), Authors Christopher C. Onyiaodike, Heather Murray, Ruiqi Zhang, Barbara J. Meyer, Fiona Jordan, Elizabeth A. Brown, Robert JB Nibbs, Helen Lyall, Naveed Sattar, Scott M. Nelson, and Dilys J. Freeman This journal article is available at Research Online:
3 Received: 24 August 2017 Accepted: 28 December 2017 Published: xx xx xxxx OPEN Pre-conception maternal erythrocyte saturated to unsaturated fatty acid ratio predicts pregnancy after natural cycle frozen embryo transfer Christopher C. Onyiaodike 1, Heather M. Murray 2, Ruiqi Zhang 2, Barbara J. Meyer 3, Fiona Jordan 4, E. Ann Brown 1, Robert J. B. Nibbs 5, Helen Lyall 1, Naveed Sattar 4, Scott M. Nelson 1 & Dilys J. Freeman 4 The environment for embryo implantation and fetal growth and development is affected by maternal nutritional, metabolic and health status. The aim of this prospective, cohort study was to test whether plasma metabolic and inflammatory biomarkers can predict pregnancy resulting from in vitro fertilisation (IVF). Women with a natural menstrual cycle undergoing frozen embryo transfer (FET) were recruited and fasting baseline blood samples were collected a mean of 3.4 days prior to the luteinising hormone (LH) surge and a non-fasting blood sample was taken on the day of FET. Ongoing pregnancy was defined by positive fetal heartbeat on ultrasound scan at day 45 post LH surge. Thirty-six pregnancies resulted from FET in 143 women. In an overall stepwise multivariable analysis, erythrocyte saturated to unsaturated fatty acid ratio was positively associated with ongoing pregnancy. A similar model incorporating day of FET covariates found that erythrocyte saturated to unsaturated fatty acid ratio, erythrocyte fatty acid average chain length and plasma log-triglycerides predicted ongoing pregnancy. In conclusion, a higher peri-conceptional saturated to unsaturated fatty acid ratio predicted ongoing pregnancy after natural cycle frozen embryo transfer and may reflect a maternal nutritional status that facilitates pregnancy success in this assisted conception scenario. The environment for embryo implantation and fetal growth and development is affected by maternal nutritional, metabolic and health status. Pre-pregnancy body mass index (BMI), to a greater extent than gestational weight gain or dietary intake, influences the maternal metabolic adaptation to pregnancy highlighting the importance of peri-conceptional health 1. In women undergoing assisted reproduction, maternal metabolic health can influence the success of treatment. For example, maternal obesity can affect oocyte and embryo quality 2, uterine receptivity 3 and ultimate success of in vitro fertilisation (IVF) 4. Promotion of a healthy pregnancy in women prior to conception is a potential approach to reduce perinatal morbidity and mortality, however evidence for good biomarkers of peri-conceptional health is lacking. The aspiration is to find new predictive markers that, prior to pregnancy, can identify women at risk of an adverse outcome and identify those who could benefit from lifestyle intervention to improve their peri-conceptional health in both natural conception and IVF scenarios. It has been suggested that metabolites present in the plasma may reflect the environment in the ovary 5. Interestingly, the type of serum fatty acid on day of oocyte retrieval has been associated with pregnancy success with high serum α-linolenic acid levels linked to a lower chance of pregnancy 6. The blood fraction in which fatty acids reside inform us of different aspects of fatty acid metabolism. Plasma fatty acids, predominately derived from phospholipids in lipoproteins, represent plasma fatty acid flux 1 School of Medicine, University of Glasgow, Glasgow, UK. 2 Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK. 3 School of Medicine, Metabolic Research Centre, University of Wollongong, Wollongong, NSW, Australia. 4 Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. 5 Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK. Correspondence and requests for materials should be addressed to D.J.F. ( dilys.freeman@glasgow.ac.uk) 1
4 Characteristic Pregnant (n = 36) Non-pregnant (n = 107) Odds ratio CI P C statistic Age (years) 35.0 (4.5) 34.7 (4.7) , Current smoker n (%) 4 (11%) 23 (22%) , SIMD quintile 1 Most affluent, 5 most deprived) 1 6 (17%) 21 (20%) , (22%) 21 (20%) , (22%) 32 (30%) , (14%) 15 (14%) , (25%) 18 (17%) referent Systolic blood pressure (mmhg) 116 (13) 115 (12) , Diastolic blood pressure (mmhg) 65 (7) 66 (9) , Height (cm) 165 (7.2) 164 (6.7) , Weight (kg) 71.5 (11.3) 68.4 (13.6) , BMI (kg/m 2 ) 26.5 (4.1) 25.5 (4.7) , Waist (cm) 88.6 (10.6) 85.6 (11.6) , Menstrual period length (days) 4.6 (1.5) 4.8 (1.0) , Cycle length (days) 28.8 (1.74) 28.8 (2.25) , Number of previous pregnancies 24 weeks 0 35 (97%) 102 (98%) >0 1 (3%) 2 (2%) 1.00* Number of previous pregnancies <24 weeks 0 27 (75%) 73 (70%) >0 9 (25%) 31 (30%) , Number of embryos transferred 1 6 (17%) 18 (18%) >1 30 (84%) 83 (82%) , Treatment IVF 13 (36%) 53 (52%) ICSI 23 (64%) 48 (48%) , Table 1. Demographic characteristics and univariate logistic regression models for prediction of ongoing pregnancy at day 45 post-lh surge. * P-value from Fisher s Exact test. Continuous variables are presented as mean (standard deviation) and continuous variables as number (%). Odds ratios are for a 1 unit increase in a variable. BMI = body mass index, CI = confidence interval, IVF = in vitro fertilisation, ICSI = intra-cytoplasmic sperm injection, SIMD = Scottish Index of Multiple Deprivation. Missing data are as follows: n = 1 pregnant (smoking status, systolic blood pressure, diastolic blood pressure, height, weight, cycle length); n = 2 pregnant (weight, BMI); n = 4 pregnant (waist); n = 6 pregnant (menstrual period length); n = 1 non-pregnant (age, smoking status, weight, BMI); n = 2 non-pregnant (waist); n = 3 non-pregnant (cycle length, number of previous pregnancies 24 weeks; number of previous pregnancies <24 weeks); n = 6 non-pregnant (number of embryos transferred; treatment); n = 8 non-pregnant (systolic blood pressure, diastolic blood pressure); n = 13 non-pregnant (menstrual period length). or turnover and are heavily influenced by fasting status. Erythrocyte fatty acid content represents an integrative measure of whole body fatty acid status over the preceding three months (the lifespan of an erythrocyte is 120 days) and erythrocytes may act as a potential storage vehicle for some key polyunsaturated fatty acids such as arachidonic acid (20:4n-6) and docosahexaenoic acid (22:6n-3) 7. Metabolomic profiling has identified maternal plasma fatty acid composition as a potential mediator of the adverse effect of pre-pregnancy BMI on pregnancy outcome 1. Thus markers of nutritional status (such as plasma and erythrocyte fatty acid composition) 8, metabolic and inflammatory markers associated with maternal insulin resistance and obesity 9,10 and inflammatory markers associated with pregnancy loss 11 could be potentially informative for predicting pregnancy success. The aim of this study was to test the ability of metabolic and inflammatory biomarkers to predict ongoing pregnancy after IVF treatment. The study was carried out in a cohort of women presenting for natural cycle frozen embryo transfer (FET). This allowed accurate timing of peri-conceptional sampling and avoided the impact of exogenous hormones on maternal metabolic profile. Methods Patient recruitment. Women, with a regular menstrual cycle (Table 1), undergoing FET in a natural cycle with no exogenous hormones were recruited from the Assisted Conception Unit (ACU) at Glasgow Royal Infirmary between October 2007 and June Indications for IVF treatment are shown in Supplemental Table 1. At recruitment patient demographics, height, weight, waist circumference were collected and Scottish Index of Multiple Deprivation (SIMD) quintile was derived from patient postcode 12. At day 10 after their last 2
5 menstrual period (LMP) date (baseline), the women attended the ACU to commence daily hormonal sampling to detect the LH surge and time embryo (from the woman s own oocyte) replacement. The initial pregnancy test (urinary hcg) was performed on day 18 post-lh surge with confirmation of clinical pregnancy by ultrasound on day 45 post-lh surge. Nine of the women with a negative pregnancy result at day 45 had tested positive on the hcg test at day 18 post-lh surge and were included in the non-pregnant at day 45 post-lh surge group. The study was carried out in accordance with the Declaration of Helsinki (2013). The study was approved by the Glasgow Royal Infirmary Research Ethics Committee (07/S0704/49) and all women in the study provided written informed consent. Blood sampling and biochemical analyses. Baseline blood samples, after at least a 10 hour fast, were collected approximately day 10 after LMP. Date of the LH surge was identified from the daily hormonal sampling and taken as day 0 gestation (Supplemental Figure 1). Baseline samples were collected prior to, or shortly after, LH surge (mean of 3.4 days prior; range 12 days prior to 1 day post). A further non-fasting blood sample was taken on the day of the FET (mean [standard deviation] 2.8 [0.9] days post-lh surge) prior to the procedure. Plasma and erythrocytes were collected after low speed centrifugation and frozen as aliquots at 80 C within 2 hours. Plasma samples were analysed for total cholesterol, triglyceride, HDL cholesterol, glucose, high sensitivity CRP, non-esterified fatty acids (NEFA), insulin, hcg, IL-6, PAI-1, PAI-2 and plasma chemokines (MCP-1 [CCL2], MIP1α [CCL3], MIP1β [CCL4], IL-8 [CXCL8] and eotaxin [CCL11]) as described in the Supplemental Methods. Erythrocyte and plasma fatty analysis was carried out as described in the Supplemental Methods. Statistical analysis. Data are reported as mean (standard deviation) for continuous measures and number (percentage) for categorical measures. Insulin, CRP, triglyceride, IL-6 and IL-8 (CXCL8) were log transformed using the natural logarithm. Missing data are indicated and statistical analysis was carried out on available data. Differences in baseline characteristics between pregnant and non-pregnant groups were tested using two sample t-tests for continuous variables and Fisher s Exact tests for categorical variables. Prediction of successful pregnancy outcome at day 45 post-lh surge was assessed by univariate logistic regression and P < 0.01 was considered significant in univariate analysis to account for multiple testing. Multivariable modelling was carried out over two phases. An initial set of stepwise logistic regression models with P-to-enter and P-to-stay < 0.15 was used to select variables from each of three variable subgroups (metabolic and inflammatory markers; erythrocyte fatty acids; plasma fatty acids) to include in the final stepwise multivariable models. Final stepwise logistic models with P-to-enter < 0.15 and P-to-stay < 0.05 were carried out using the variables selected from the initial models. Results are reported as odds ratio (OR) [95% confidence interval (CI)], Chi square score and associated P-value and the C-statistic for the area under the curve. Odds ratios represent an increase of 1 unit for continuous variables unless otherwise stated. A priori power calculations indicated at least 80% power at the 5% significant level to detect 0.47 fold differences in the majority of parameters tested as a single comparison between successful and failed pregnancy groups with n = 36 pregnancies (Supplemental Methods and Supplemental Table 2). All analyses were performed using the statistical software SAS (Version 9.3, SAS Institute, Cary, NC, USA). Data availability. Data may be available on request, subject to ethical approval for the specific analysis requested, DOI Results Patient characteristics. A total of 196 FET cycles were started in the study, of which 161 were completed. For the purposes of the current analysis, repeat attempts within the study were excluded. There were 143 unique first attempts within the study period from which there were 107 unsuccessful pregnancies and 36 ongoing pregnancies defined by positive fetal heartbeat on ultrasound scan at day 45 post-lh surge (Supplemental Figure 2). Women taking part in the study were on average 35 years of age and had normal blood pressure (Table 1). Women who became pregnant did not differ from those who did not in terms of baseline age, smoking habit, obesity as measured by BMI or waist circumference, or socio-economic status. There were no differences in their previous fertility history. There were no differences between groups in the proportion of women undergoing IVF or intra-cytoplasmic sperm injection (ICSI), nor in the proportions of women having one or more than one embryo transferred. Univariate models for prediction of ongoing pregnancy by baseline demographics and biomarkers. None of the recorded demographic variables predicted ongoing pregnancy at day 45 post-lh surge (Table 1). Baseline erythrocyte unsaturated and saturated fatty acid concentrations were highly correlated with each other (Supplemental Figure 3). When either saturated or unsaturated erythrocyte fatty acids, or their sum (total fatty acid concentration), were individually included in a univariate logistic regression model, none predicted ongoing pregnancy (Table 2). However, if saturated and unsaturated fatty acids were entered simultaneously into a multivariable model, each was a highly significant predictor (Combined model 1, Table 2). This suggests that saturated (positive direction) and unsaturated (negative direction) fatty acids have significant individual effects that are dependent on each other. To establish the best way to capture this information, a number of univariate and multivariable models incorporating the total of saturated and unsaturated fatty acids, their difference and their ratio were carried out (Table 2). The model with the lowest Akaike Information Criterion (97.4) was the ratio of saturated to unsaturated fatty acids alone and this measure was used in all univariate and multivariate models. Analysis of baseline plasma, day of FET erythrocyte and day of FET plasma saturated and unsaturated fatty acids yielded similar results (data not shown) and their ratios were similarly used in logistic regression analysis. 3
6 Variable Odds ratio CI P C statistic AIC Univariate models Saturated fatty acid (nmol/ml) , Unsaturated fatty acid (nmol/ml) , Total fatty acid (nmol/ml) , Saturated/unsaturated fatty acid ratio (0.05 units) , Saturated unsaturated fatty acid difference (nmol/ml) , Combined model Saturated fatty acid (nmol/ml) , Unsaturated fatty acid (nmol/ml) , Combined model Total fatty acid (nmol/ml) , Saturated unsaturated fatty acid difference (nmol/ml) , Combined model Total fatty acids (nmol/ml) , Saturated/unsaturated fatty acid ratio (0.05 units) , Table 2. Logistic regression models incorporating measures of baseline erythrocyte saturated and unsaturated fatty acids for prediction of ongoing pregnancy at day 45 post LH-surge. Odds ratios are for a 1 unit increase in a variable. AIC = Akaike Information Criterion, CI = confidence interval. Plasma and erythrocyte fatty acid data was missing for n = 1 non-pregnant participant. Baseline concentrations of plasma metabolic and inflammatory biomarkers (Table 3, Supplemental Table 3), erythrocyte fatty acids and summary measures (Table 3, Supplemental Tables 4 and 5) and plasma fatty acids and summary measures (Table 3, Supplemental Tables 6 and 7) are shown. Univariate analysis was carried out and variables that predicted ongoing pregnancy with P < 0.15 are shown in Table 3. These variables were included in multivariable analysis. On univariate analysis only baseline erythrocyte saturated to unsaturated fatty acid ratio predicted ongoing success at day 45 post-lh surge (P < 0.001) (Supplemental Figure 4). Univariate models for prediction of successful pregnancy outcome by day of FET, non-fasting biomarkers. Non-fasting blood samples were taken just prior to the FET procedure on median day 3 post-lh surge and metabolic and inflammatory biomarkers assessed as well as erythrocyte and plasma fatty acids (data not shown). Day of FET non-fasting plasma log-triglyceride (3.48 [1.43, 8.48], P = 0.006, C-statistic 0.66) was associated with a higher odds of ongoing pregnancy and additionally insulin, CRP and NEFA (all P < 0.15) were included in stepwise multivariable modelling. Erythrocyte 14:0 (1.09 [1.02, 1.16], P = , C-statistic 0.69), n-6 polyunsaturated fatty acids (PUFA) (0.56 [0.36, 0.86], P = , C-statistic 0.68), average chain length (0.51, [0.33, 0.76], P = , C-statistic 0.73) and saturated/unsaturated fatty acid ratio (0.05 units) (6.70, [2.25, 19.88], P = , C-statistic 0.73) were associated with ongoing pregnancy. Additionally erythrocyte 14:1 n-7, 18:1 n-7, 18:3 n-3, 20:1 n-9, 20:3 n-6, 20:4 n-6, 22:4 n-6, 22:5 n-3, 24:1 n-9, unsaturated index and % C20 22 fatty acids (all P < 0.15) were included in stepwise multivariable modelling. Plasma 14:0 (1.01 [1.00, 1.02], P = 0.008, C-statistic 0.66), 17:0 (1.07 [1.02, 1.12], P = 0.007, C-statistic 0.68), plasma saturated/unsaturated fatty acid ratio (0.05 units) (2.31 [1.30, 4.09], P = , C-statistic 0.69), n-6 PUFA (0.80 [0.68, 0.93] P = , C-statistic 0.70), unsaturated index (0.91 [0.84, 0.98], P = , C-statistic 0.68) and fatty acid average chain length (0.05 units) (0.65 [0.48, 0.88], P = , C-statistic 0.70) were associated with ongoing pregnancy. Plasma 12:0, 14:1 n-7, 16:0, 16:1 n-7; 18:0, 18:1 n-9, 20:1 n-9, 24:1 n-9 and % C20 22 fatty acids (all P < 0.15) were also included in stepwise multivariable modelling. Multivariable models for prediction of ongoing pregnancy. Initial stepwise multivariable models (P-to-enter, P-to-stay < 0.15) were carried out using the baseline and day of FET variables, selected at P < 0.15 on univariate analysis (Table 3 for baseline measures and listed above for day of FET measures). This resulted in the selection of log triglyceride, log IL-6, log insulin, erythrocyte saturated to unsaturated fatty acid ratio, average chain length, 18:3 n-3, 20:1 n-9 and 24:1 n-9; and plasma saturated to unsaturated fatty acid ratio, 17:0 and 24:1 n-9 for inclusion in the final stepwise models. Table 4 shows the final multivariable logistic regression models for predictors of ongoing pregnancy. The only baseline predictor of ongoing pregnancy remaining after stepwise multivariable analysis (P-to-enter < 0.15, P-to-stay < 0.05) was saturated to unsaturated fatty acid ratio with an odds ratio of 7.19 (2.33, 22.17) per 0.05 unit increase, P = The C-statistic for this prediction model was When non-fasted day of FET covariates were used to predict ongoing pregnancy, erythrocyte saturated to unsaturated fatty acid ratio OR 7.11 (2.05, 24.71) per 0.05 unit increase, P = 0.002, erythrocyte fatty acid average chain length OR 0.58 (0.37, 0.92) per 0.05 unit increase, P = and plasma log-triglycerides OR 4.23 (1.05, 16.95) P = predicted ongoing pregnancy. The C-statistic for the prediction model based on non-fasting day of FET covariates was
7 Variable Pregnant (n = 36) Non-pregnant (n = 107) Odds Ratio Confidence Interval P C-statistic Plasma metabolic and inflammatory markers Triglyceride* (mmol/l) 1.01 (1.47) 0.90 (1.48) 2.15 (0.82, 5.63) IL-6* (pg/ml) 1.14 (2.01) 0.90 (1.76) 1.86 (0.93, 3.72) Erythrocyte fatty acids and summary measures 14:0 (nmol/ml) 12.8 (7.06) 9.60 (6.35) , :0 (nmol/ml) 6.94 (3.06) 5.72 (2.04) , :1 n-7 (nmol/ml) 6.31 (8.89) (10.98) , :1 n-9 (nmol/ml) 4.24 (1.06) 4.94 (1.35) , :1 n-9 (nmol/ml) 64.5 (9.8) 70.2 (12.6) , :2 n-6 (nmol/ml) 0.66 (1.24) 1.30 (1.77) , :4 n-6 (nmol/ml) 38.5 (6.7) 43.1 (10.3) , :3 n-3 (nmol/ml) 3.93 (2.08) 2.95 (2.22) , % Total n (1.27) 28.4 (1.3) , Unsaturated Index (4.1) (4.0) , Average chain length (0.05 units) (0.05) (0.06) , Saturated/unsaturated ratio (0.05 units) 0.78 (0.02) 0.76 (0.02) , Plasma fatty acids and summary measures 14:0 (nmol/ml) 118 (51) 98.3 (45.8) , :0 (nmol/ml) 30.0 (10.1) 25.6 (9.8) , :0 (nmol/ml) 618 (117) 577 (98) , :1 n-7 (nmol/ml) 41.7 (35.1) 29.6 (29.1) , :1 n-9 (nmol/ml) 88.5 (10.4) 94.3 (15.9) , Saturated/unsaturated ratio (0.05 units) 0.52 (0.05) 0.49 (0.04) , % Total n (3.09) 38.5 (3.4) , Average chain length (0.05 units) (0.08) (0.09) , Table 3. Baseline variable concentrations and univariate logistic regression models for prediction of ongoing pregnancy at day 45 post-lh surge where P < Continuous variables are presented as mean (standard deviation) or * geometric means (standard deviation). Odds ratios are for a 1 unit increase in a variable apart from. IL-6 = interleukin 6. IL-6 data was missing for n = 1 pregnant and n = 50 non-pregnant participants. Plasma triglyceride and plasma and erythrocyte fatty acid data was missing for n = 1 non-pregnant participant. Discussion In women undergoing natural cycle FET, the erythrocyte ratio of saturated to unsaturated fatty acids prior to pregnancy predicted ongoing pregnancy at day 45 post-lh surge. Similarly, on day of FET, higher erythrocyte saturated to unsaturated fatty acid ratio and shorter average chain length, in addition to higher concentrations of plasma triglycerides, predicted ongoing pregnancy. Erythrocytes have a lifespan of 120 days, though their fatty acid composition may reflect more recent changes in concentration 13. As erythrocyte composition reflects that of tissue stores 14, this suggests that the quality of stored fatty acids has an impact on pregnancy outcome. A higher ratio of saturated to unsaturated fatty acids in the diet is commonly linked to metabolic diseases such as coronary heart disease, however this issue is complex and there is a lack of consensus on the scientific evidence for these associations 15,16. Erythrocyte fatty acid composition is unaffected by fasting status, thus it is reassuring to see similar erythrocyte predictors at both time points. The prediction of ongoing pregnancy by non-fasting plasma triglyceride levels on day of FET, which are increased post-prandially, suggests that pre-implantation maternal handling of dietary lipids may be important in the preparation for pregnancy. Serum fatty acids have previously been linked to pregnancy outcome in an IVF population. Higher serum α-linolenic acid concentrations collected on day of oocyte retrieval were associated with a lower chance of pregnancy, although this may not be independent of endometriosis 6. These data were not replicated in a subsequent study which instead found a high linoleic acid to α-linolenic acid ratio was associated with pregnancy success after adjustment for confounders 17. Taken together with our study, these preliminary data indicate that the proportions of plasma fatty acids of different functionality may be an important factor in pregnancy success. Maternal metabolic status could influence fertility by improving oocyte/embryo quality or endometrial receptivity. The mammalian blastocyst is dependent on its own energy stores to drive cell division 18 and endogenous triglycerides are a key energy source during oocyte maturation and preimplantation embryo development 19. Mouse models suggest that fatty acid oxidation is critical for oocyte function, embryo development, implantation and endometrial stromal cell decidualisation 20,21. In human oocytes 80% of fatty acids are saturated 22,23. Exposure of the blastocyst to external lipid appears to be cytotoxic 24 which suggests that fatty acid supply via uterine secretions may not occur. Human embryos that successfully develop to blastocysts have lower triglyceride content, although it is difficult to determine if this is due to less initial storage or greater oxidation rates providing more energy while the blastocyst was being formed 2. A well-stocked oocyte in terms of lipid available for oxidation (i.e. saturated fat) may have an advantage over one that lacks such lipid. 5
8 Multivariable Visit/Covariate Odds Ratio (95% confidence interval) P-value C-statistic (Area Under Curve) Baseline (mean of 3.4 days prior to LH surge) Erythrocyte saturated/unsaturated fatty acid ratio (0.05 units) 7.19 (2.33, 22.17) Day of FET (mean of 2.8 days post-lh surge) Erythrocyte saturated/unsaturated fatty acid ratio (0.05 units) 7.11 (2.05, 24.71) Erythrocyte fatty acid average chain length (0.05 units) 0.58 (0.37, 0.92) Log [triglyceride (mmol/l)] 4.23 (1.05, 16.95) Table 4. Multivariable logistic regression models for predicting pregnancy success at 45 days post-lh surge. Covariates to enter the stepwise logistic regression were initially selected using baseline, or day of FET (mean 2.8 days post-lh surge) stepwise logistic regression models run for all covariates (plasma and erythrocyte metabolic, inflammatory and fatty acid markers) P-to-enter and P-to-stay < 0.15). Variables included were baseline or day of FET triglyceride, IL-6 and insulin; erythrocyte 18:3 n-3, 20:1 n-9, 24:1 n-9, saturated/ unsaturated fatty acid ratio and average chain length; and plasma 17:0, 24:1 n-9 and saturated/unsaturated fatty acid ratio. The final multivariable model is a stepwise model with P-to-enter and P-to-stay < Data shown are the odds ratio (for the given unit of change), and the 95% confidence interval, with the associated Chi square score, P-value, and the C-statistic (for the Area under the Curve). FET = frozen embryo transfer. The oocytes in the current study were retrieved at least three months prior to FET so our baseline biomarkers do not necessarily reflect the environment of oocyte development but will reflect the implantation environment. Uterine receptivity is affected by changes in metabolic environment associated with maternal obesity or polycystic ovarian syndrome (PCOS) (reviewed in 25 ). Pregnancy hormones influenced adipokine secretion from and increased lipolysis in an adipocyte cell line 26. The pregnancy hormone-conditioned medium from these adipocytes increased receptivity marker expression in an endometrial cell line 26. Adipocytes contain predominately saturated fatty acids whose composition reflects that of plasma fatty acids which in turn are influenced by dietary intake 27. A significant increase in fatty acid release into plasma from adipocytes may lead to an increase in the saturated to unsaturated fatty acid ratio. Weight loss in overweight women with PCOS increased endometrial expression of genes involved in glucose homeostasis, which may improve endometrial receptivity 28. Improvements in insulin sensitivity at the endometrium may also enhance tissue fatty acid uptake and oxidation. The analysis of non-fasting biomarkers taken immediately prior to FET produced a predictive model with a higher C statistic than that using fasting biomarkers pre-lh surge. Erythrocyte fatty acid average chain length appeared as a negative predictor reinforcing the suggestion that shorter chain fatty acids commonly used in energy storage are important for pregnancy success. It is interesting that higher plasma triglyceride concentrations were predictive of an ongoing pregnancy in the non-fasting biomarker analysis. Plasma triglyceride concentrations under these conditions represent recent post prandial intake of lipid. This might suggest that women with higher plasma levels of dietary lipids may be have better endometrial receptivity or improved oocyte quality. A recent report that higher dietary dairy intake was associated with increased live birth rate in an IVF population, at least in older women, may support this concept 29. FET of autologous or donor embryos comprises 37.7% of assisted conception cycles currently undertaken in the United Sates (CDC Assisted Reproductive Technology Annual Report 2015). Biomarkers, which can indicate the potential for the success of different assisted conception protocols, are helpful both in tailoring treatment to the individual patients and in devising intervention strategies, e.g. dietary supplementation or intervention, that may improve success rates in assisted conception treatment. One strength of our study was the prospective design in an IVF population allowing accurate peri-conceptional timing of sampling. All women had a natural menstrual cycle and results were free from the impact of exogenous hormones. Use of frozen, rather than fresh, embryos may mean our results are specific to frozen embryos. We did not observe the expected associations between maternal BMI, smoking or number of embryos transferred 30 and ongoing pregnancy probably due to the small number of pregnancies and the limited BMI range within our population limiting statistical power. Pregnancy success rates in this study were low reflecting day 3 embryo transfers and the absence of pre-implantation genetic screening. Nine women who tested positive for pregnancy on hcg test at day 18 post-lh surge, but negative at day 45 post-lh surge ultrasound scan were included as unsuccessful pregnancies. These women may represent a particular subgroup where implantation is successful, but pregnancy maintenance is not. This group was too small to be analysed separately and as our a priori pregnancy outcome was positive fetal heartbeat at day 45 post-lh surge we included them in our unsuccessful pregnancy group. We cannot determine whether the relationships we observed only occur under conditions of compromised fertility or extend to natural conception in the wider population. The peri-conceptional period is a key opportunity for interventional strategies that is routinely missed due to management of most pregnancies commencing at antenatal booking around weeks of gestation. Evidence-based strategies, delivered either in the preconception or antenatal periods, to reduce adverse pregnancy outcomes are being sought. If our results are validated, the saturated to unsaturated fat ratio in erythrocytes could be explored as a marker of maternal metabolic health. However it should be noted that the absolute difference in saturated to unsaturated fatty acid ratio between groups was very small and while it may suggest potential biological metabolic pathways of importance in conception it is unlikely to be a good biomarker in itself. 6
9 In summary, higher peri-conceptional saturated to unsaturated fatty acid ratio predicted ongoing pregnancy after natural cycle FET and may reflect a maternal nutritional status that facilitates pregnancy success in this assisted conception scenario. Dietary interventions could be used to manipulate the saturated to unsaturated fatty acid ratio and better assess its effect on pregnancy outcome both in assisted conception and free-living populations. References 1. Hellmuth, C. et al. Association of maternal prepregnancy BMI with metabolomic profile across gestation. International journal of obesity (2005) 41, , (2017). 2. Leary, C., Leese, H. J. & Sturmey, R. G. Human embryos from overweight and obese women display phenotypic and metabolic abnormalities. Human reproduction (Oxford, England) 30, , (2015). 3. Bellver, J. et al. Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors. Fertility and sterility 100, , (2013). 4. Provost, M. P. et al. Pregnancy outcomes decline with increasing recipient body mass index: an analysis of 22,317 fresh donor/ recipient cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System registry. Fertility and sterility 105, , (2016). 5. Robker, R. L. et al. Obese women exhibit differences in ovarian metabolites, hormones, and gene expression compared with moderate-weight women. The Journal of clinical endocrinology and metabolism 94, , (2009). 6. Jungheim, E. S., Macones, G. A., Odem, R. R., Patterson, B. W. & Moley, K. H. Elevated serum alpha-linolenic acid levels are associated with decreased chance of pregnancy after in vitro fertilization. Fertility and sterility 96, , fertnstert (2011). 7. Ghebremeskel, K. et al. Blood fatty acid composition of pregnant and nonpregnant Korean women: red cells may act as a reservoir of arachidonic acid and docosahexaenoic acid for utilization by the developing fetus. Lipids 35, (2000). 8. Stewart, F. et al. Longitudinal assessment of erythrocyte fatty acid composition throughout pregnancy and post partum. Lipids 42, , (2007). 9. Nelson, S. M., Matthews, P. & Poston, L. Maternal metabolism and obesity: modifiable determinants of pregnancy outcome. Human reproduction update 16, , (2010). 10. Ramsay, J. E. et al. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. The Journal of clinical endocrinology and metabolism 87, (2002). 11. Madigan, J. et al. Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipients. Journal of immunology (Baltimore, Md.: 1950) 184, , (2010). 12. Scottish Index of Multiple Deprivation2004: Summary Technical Report. Scottish Executive. Edinburgh. (Scottish Executive, Edinburgh, 2004). 13. Skeaff, C. M., Hodson, L. & McKenzie, J. E. Dietary-induced changes in fatty acid composition of human plasma, platelet, and erythrocyte lipids follow a similar time course. The Journal of nutrition 136, (2006). 14. Arab, L. Biomarkers of fat and fatty acid intake. The Journal of nutrition 133(Suppl 3), 925S 932S (2003). 15. Hammad, S., Pu, S. & Jones, P. J. Current Evidence Supporting the Link Between Dietary Fatty Acids and Cardiovascular Disease. Lipids 51, , (2016). 16. Ramsden, C. E. et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment ( ). BMJ (Clinical research ed.) 353, i1246, (2016). 17. Jungheim, E. S., Frolova, A. I., Jiang, H. & Riley, J. K. Relationship between serum polyunsaturated fatty acids and pregnancy in women undergoing in vitro fertilization. The Journal of clinical endocrinology and metabolism 98, E , org/ /jc (2013). 18. Gardner, D. K. Changes in requirements and utilization of nutrients during mammalian preimplantation embryo development and their significance in embryo culture. Theriogenology 49, (1998). 19. Ferguson, E. M. & Leese, H. J. A potential role for triglyceride as an energy source during bovine oocyte maturation and early embryo development. Molecular reproduction and development 73, , (2006). 20. Dunning, K. R. et al. Beta-oxidation is essential for mouse oocyte developmental competence and early embryo development. Biol Reprod 83, , (2010). 21. Tsai, J. H., Chi, M. M., Schulte, M. B. & Moley, K. H. The fatty acid beta-oxidation pathway is important for decidualization of endometrial stromal cells in both humans and mice. Biol Reprod 90, 34, (2014). 22. Kim, J. Y., Kinoshita, M., Ohnishi, M. & Fukui, Y. Lipid and fatty acid analysis of fresh and frozen-thawed immature and in vitro matured bovine oocytes. Reproduction 122, (2001). 23. Matorras, R. et al. Fatty acid composition of fertilization-failed human oocytes. Human reproduction (Oxford, England) 13, (1998). 24. Cagnone, G. & Sirard, M. A. The impact of exposure to serum lipids during in vitro culture on the transcriptome of bovine blastocysts. Theriogenology 81, e , (2014). 25. Schulte, M. M., Tsai, J. H. & Moley, K. H. Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation. Reprod Sci 22, 6 14, (2015). 26. Gamundi-Segura, S., Serna, J., Oehninger, S., Horcajadas, J. A. & Arbones-Mainar, J. M. Effects of adipocyte-secreted factors on decidualized endometrial cells: modulation of endometrial receptivity in vitro. Journal of physiology and biochemistry 71, , (2015). 27. Hodson, L. et al. Micro-techniques for analysis of human adipose tissue fatty acid composition in dietary studies. Nutr Metab Cardiovasc Dis 23, , (2013). 28. Ujvari, D. et al. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome. Human reproduction (Oxford, England) 29, , (2014). 29. Afeiche, M. C. et al. Dairy intake in relation to in vitro fertilization outcomes among women from a fertility clinic. Human reproduction (Oxford, England) 31, , (2016). 30. Lawlor, D. A. & Nelson, S. M. Effect of age on decisions about the numbers of embryos to transfer in assisted conception: a prospective study. Lancet 379, , (2012). Acknowledgements We acknowledge the generous support of: The Wellbeing of Women/Royal College of Obstetrics and Gynaecology Research Grant (RG/939/07), The Biochemical Society Travel Grant (101008), The Carnegie Trust, The Harold Hyam Wingate Foundation and University of Wollongong Study Leave Assistance Grants. 7
10 Author Contributions C.C.O. recruited patients, collected blood samples and patient information, assisted in data analysis and interpretation. H.M.M. statistical analysis. R.Z. statistical analysis. B.J.M. fatty acid GC profiling, data analysis and interpretation, assisted in manuscript preparation. F.J. inflammatory marker analysis. E.A.B. collected blood samples, fatty acid extractions, ELISA and plasma lipid analyses. R.J.B.N. conceived idea, secured funding, contributed to data interpretation. H.L. facilitated patient recruitment, secured funding, contributed to data interpretation. N.S. - conceived idea, secured funding, contributed to data interpretation. S.M.N. clinical lead, facilitated patient recruitment, conceived idea, secured funding, assisted in manuscript preparation. D.J.F. principal investigator and supervisor for C.C.O., data analysis, manuscript preparation, conceived idea and secured funding. Additional Information Supplementary information accompanies this paper at Competing Interests: The authors declare that they have no competing interests. Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit The Author(s)
Role of DHA in Early Life Nutrition in the First 1000 days
Role of DHA in Early Life Nutrition in the First 1000 days Role of DHA in Early Life Nutrition in the First 1000 days Professor Barbara School of Medicine, University of Wollongong, NSW, Australia Docosahexaenoic
More informationHow to advise the couple planning to conceive: Modifiable factors that may (or may not) impact fertility
How to advise the couple planning to conceive: Modifiable factors that may (or may not) impact fertility I have nothing to disclose Disclosures Heather Huddleston, MD Associate Professor of Clinical Medicine
More informationMinimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology
Minimising IVF related mortality and morbidity Scott Nelson Muirhead Professor in Obstetrics & Gynaecology We rarely say no - so what I will cover today VTE as an example of a modifiable IVF complication
More information902 Biomed Environ Sci, 2014; 27(11):
902 Biomed Environ Sci, 2014; 27(11): 902-906 Letter to the Editor Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type
More informationThrombosis during assisted reproduction. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology
Thrombosis during assisted reproduction Scott Nelson Muirhead Chair in Obstetrics & Gynaecology ART can be as safe as natural pregnancy!! What used to be the risk of thrombosis in ART!! We can use AMH
More informationMETABOLIC SYNDROME IN REPRODUCTIVE FEMALES
METABOLIC SYNDROME IN REPRODUCTIVE FEMALES John J. Orris, D.O., M.B.A Division Head, Reproductive Endocrinology & Infertility, Main Line Health System Associate Professor, Drexel University College of
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationCommissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services
Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services Reference No: Version: 2 Ratified by: EMSCGP006V2 EMSCG Date ratified:
More informationFertility Policy. December Introduction
Fertility Policy December 2015 Introduction Camden Clinical Commissioning Group (CCG) is responsible for commissioning a range of health services including hospital, mental health and community services
More informationTable S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).
Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52
More informationSupplementary Online Content
Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia
More informationTable S2: Anthropometric, clinical, cardiovascular and appetite outcome changes over 8 weeks (baseline-week 8) by snack group
Table S1: Nutrient composition of cracker and almond snacks Cracker* Almond** Weight, g 77.5 g (5 sheets) 56.7 g (2 oz.) Energy, kcal 338 364 Carbohydrate, g (kcal) 62.5 12.6 Dietary fiber, g 2.5 8.1 Protein,
More informationFertility care for women diagnosed with cancer
Saint Mary s Hospital Department of Reproductive Medicine Information for Patients Fertility care for women diagnosed with cancer Contents Page Overview... 2 Our service... 2 Effects of cancer treatment
More informationORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationPolicy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018)
Islington CCG Fertility Policy First approved: 29 January 2015 Policy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018) Introduction Islington CCG
More informationBACKGROUNDER. Pregnitude A Fertility Dietary Supplement for Reproductive Support Offers an Additional Option for Women Who Are Trying to Conceive
BACKGROUNDER Pregnitude A Fertility Dietary Supplement for Reproductive Support Offers an Additional Option for Women Who Are Trying to Conceive Studies find that increased chances of ovulation, menstrual
More informationEGG BANKS program at clinique ovo
EGG BANKS program at clinique ovo HISTORY The first pregnancy resulting from egg donation in an IVF cycle was in 1983 Egg donation plays an important role in assisted reproductive technologies since it
More informationNHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs
NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO
More informationUniversal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D.
Universal Embryo Cryopreservation: Frozen versus Fresh Transfer Zaher Merhi, M.D. Disclosure: None Fewer complications with IVF 1.5% children in US are born through ART 1.1 million children since 2006
More informationASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE
ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE Version 1.0 Page 1 of 11 MARCH 2014 POLICY DOCUMENT VERSION CONTROL CERTIFICATE TITLE Title: Assisted Conception
More information3. Metformin therapy for PCOS
1. Introduction The key clinical features of polycystic ovary syndrome (PCOS) are hyperandrogenism (hirsutism, acne, alopecia) and menstrual irregularity with associated anovulatory infertility. 1 The
More informationwoman: the laboratory s role
Investigation of the infertile obese woman: the laboratory s role R. LEVY and I. CEDRIN-DURNERIN, DURNERIN P. LEVEILLE, N. SERMONDADE, C. FAURE, S. HERCBERG and S. CZERNICHOW Histologie Embryologie Cytogénétique
More informationCOMMISSIONING POLICY. Tertiary treatment for assisted conception services
Final Version COMMISSIONING POLICY Tertiary treatment for assisted conception services Designated providers for patients registered with a Worcestershire GP BMI The Priory Hospital, Birmingham - 1 - Commissioning
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,
More informationPolicy statement. Commissioning of Fertility treatments
Policy statement Commissioning of Fertility treatments NB: The policy relating to commissioning of fertility treatments is unchanged from the version approved by the CCG in March 2017. The clinical thresholds
More informationInfluence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser
Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte
More informationBlood fatty acids understanding the relevance of different tissue fractions and interpreting circulating concentrations.
Blood fatty acids understanding the relevance of different tissue fractions and interpreting circulating concentrations Leanne Hodson Fatty acid composition as a biomarker of intake Complements dietary
More informationSt Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16
St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16 1 Standard Operating Procedure St Helens CCG NHS Funded Treatment for Sub Fertility Policy Version 1 Implementation Date May 2015 Review
More informationThe effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study
Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi
More informationERA. Endometrial Receptivity Analysis. Patented since
Endometrial Receptivity Analysis Patented since 2009 www.igenomix.com ERA ERA analyzes by NGS the expression of 236 genes in order to determine the personalized window of implantation for each patient.
More informationEast and North Hertfordshire CCG. Fertility treatment and referral criteria for tertiary level assisted conception
East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception December 2015 1 1. Introduction This policy sets out the entitlement and service that will
More informationApproved January Waltham Forest CCG Fertility policy
Approved January 2015 Waltham Forest CCG Fertility policy Contents 1 Introduction 1 2 Individual Funding Requests 1 2.1 Eligibility criteria 1 2.2 Number of cycles funded 2 2.3 Treatment Pathway 3 Page
More informationSince 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight.
Impact of metabolic comorbidity on the association between body mass index and health-related quality of life: a Scotland-wide cross-sectional study of 5,608 participants Dr. Zia Ul Haq Doctoral Research
More information300 Biomed Environ Sci, 2018; 31(4):
300 Biomed Environ Sci, 2018; 31(4): 300-305 Letter to the Editor Combined Influence of Insulin Resistance and Inflammatory Biomarkers on Type 2 Diabetes: A Population-based Prospective Cohort Study of
More informationRelationship between Energy Expenditure Related Factors and Oxidative Stress in Follicular Fluid
Original Article Relationship between Energy Expenditure Related Factors and Oxidative Stress in Follicular Fluid Abstract This study evaluated the impact of body mass index (BMI), total calorie intake
More informationDr Manuela Toledo - Procedures in ART -
Dr Manuela Toledo - Procedures in ART - Fertility Specialist MBBS FRANZCOG MMed CREI Specialities: IVF & infertility Fertility preservation Consulting Locations East Melbourne Planning a pregnancy - Folic
More informationFreeze-All Policy: Is It Right for Everyone?
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/online-education/non-certified-non-accredited/freeze-all-policy-it-righteveryone/9879/
More informationEpidemiology and Prevention
Epidemiology and Prevention Associations of Pregnancy Complications With Calculated Cardiovascular Disease Risk and Cardiovascular Risk Factors in Middle Age The Avon Longitudinal Study of Parents and
More informationDRAFT Policy for the Provision of NHS funded Gamete Retrieval and Cryopreservation for the Preservation of Fertility
NHS Birmingham and Solihull Clinical Commissioning Group NHS Sandwell and West Birmingham Clinical Commissioning Group DRAFT Policy for the Provision of NHS funded Gamete Retrieval and Cryopreservation
More informationFertility Preservation By Dr Mary Birdsall Chair, Fertility Associates
Fertility Preservation By Dr Mary Birdsall Chair, Fertility Associates What can you put in the Freezer and why would you? Sperm Embryos Eggs Ovarian Tissue Freezing Sperm 60 years ago first human pregnancy
More informationAdoption and Foster Care
GLOSSARY Family building via Adoption and Foster Care October 2018 www.familyequality.org/resources A Anonymous Donor: A person who donated sperm or eggs with the intention of never meeting resulting children.
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationPolycystic ovary syndrome (PCOS)
Information for patients Polycystic ovary syndrome (PCOS) What is polycystic ovary syndrome? Polycystic ovary syndrome (PCOS) is a condition which can affect a woman s menstrual cycle, fertility, hormones
More informationReplacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins
Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins Muller H, Jordal O, et al. (998) Replacement of partially hydrogenated soybean
More informationConsultations and Assessment Fertility Specialist consultation 180 Ultrasound scan of uterus and ovaries 100 AMH measurement 80 Semen analysis 100
We hope this price list will help you assess the cost of your consultations, investigations and treatment. It provides information about what is included in the cost and how we make a refund if your treatment
More informationHALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page
HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO TREATMENT 3 4. DEFINITION
More informationPrediction modeling for live birth in in vitro fertilization. Kristen E. Gray. A dissertation. submitted in partial fulfillment of the
Prediction modeling for live birth in in vitro fertilization Kristen E. Gray A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington
More informationTHE FIRST NINE MONTHS AND CHILDHOOD OBESITY. Deborah A Lawlor MRC Integrative Epidemiology Unit
THE FIRST NINE MONTHS AND CHILDHOOD OBESITY Deborah A Lawlor MRC Integrative Epidemiology Unit d.a.lawlor@bristol.ac.uk Sample size (N of children)
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationFertility treatment and referral criteria for tertiary level assisted conception
Fertility treatment and referral criteria for tertiary level assisted conception Version Number Name of Originator/Author Cross Reference V2 East of England Consortium Commissioning Policy for Fertility
More informationInterpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used
Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara
More informationIs it the seed or the soil? Arthur Leader, MD, FRCSC
The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events
More informationSupport for Fertility and Infertility Treatment
Support for Fertility and Infertility Treatment Obesity causes an alteration to the hormones associated with women fertility Many different studies have concluded that obesity is related to impaired fertility.
More informationINDICATIONS OF IVF/ICSI
PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian
More informationRecommended Interim Policy Statement 150: Assisted Conception Services
Southampton City Clinical Commissioning Group (CCG) took on commissioning responsibility for Assisted Conception Services from 1 April 2013 for its population and agreed to adopt the interim policy recommendations
More informationA multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of
A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of Endometrioma and deep infiltrating endometriosis Professor C. Chapron and the Group
More informationHow to Select an Egg Donor
How to Select an Egg Donor How to Select an Egg Donor Egg donation entails the fertilization of eggs of a young woman and transfer of the resulting embryo or embryos into the intended mother uterus. In
More informationIN VITRO FERTILISATION (IVF)
IN VITRO FERTILISATION (IVF) Pre Treatment - first cycle 785 Medical Consultation 225 Nurse Planning 235 Baseline ultrasound scan of uterus and ovaries HIV, Hep B antibodies, Hep B antigen, Hep C blood
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationObesity and PCOS. Robert Norman The Robinson Institute for reproductive health and regenerative medicine The University of Adelaide
Obesity and PCOS Robert Norman The Robinson Institute for reproductive health and regenerative medicine The University of Adelaide Disclosures Honoraria and research grants from MSD, Merck Serono, Ferring
More informationHaringey CCG Fertility Policy April 2014
Haringey CCG Fertility Policy April 2014 1 SUMMARY This policy describes the clinical pathways and entry criteria for Haringey patients wishing to access NHS funded fertility treatment. 2 RESPONSIBLE PERSON:
More informationMetabolic Programming. Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD
Metabolic Programming Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD nutritional stress/stimuli organogenesis of target tissues early period critical window consequence of stress/stimuli are
More informationMilder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization
Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization Revelli et al. Reproductive Biology and Endocrinology 2011, 9:25 Presenter: R2 孫怡虹 Background
More informationT39: Fertility Policy Checklist
Patient Name: Address: Date of Birth: NHS Number: Consultant/Service to whom referral will be made: Institution Lifestyle Information Latest BMI: Latest BP: Smoking Status: Has the patient been referred
More informationIVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman
IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major
More informationPattern of lipid biomarkers and risk of cardiovascular disease
Pattern of lipid biomarkers and risk of cardiovascular disease Robert Clarke Clinical Trial Service Unit University of Oxford 9 January 2017 Biomarkers for dietary fats Blood lipids (LDL, HDL, triglycerides,
More informationPolycystic Ovary Disease: A Common Endocrine Disorder in Women
Polycystic Ovary Disease: A Common Endocrine Disorder in Women Paul Kaplan, M.D. Clinical Professor of Reproductive Endocrinology - OHSU Courtesy Senior Research Associate, Human Physiology University
More informationCouples Information Leaflet
Couples Information Leaflet This project was funded by the National Institute for Health Research, Health Technology Assessment Programme (project number 13/115/82) You are due to undergo in vitro fertilisation
More informationBlackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception
1 Introduction Blackpool CCG Policies for the Commissioning of Healthcare Assisted Conception 1.1 This policy describes circumstances in which NHS Blackpool Clinical Commissioning Group (CCG) will fund
More informationBumiputera Sarawak Bumiputera Sabah. Others Foreigner. Had previous natural pregnancy Previous IVF pregnancies. IVF live births.
a. Date of notification: b. Name of reporting site: c.name of doctor in charge: AI : FEMALE PATIENT DETAILS & DEMOGRAPHICS (Instruction: if Mykad is not available, please complete Old IC or other ID document
More informationGOVERNING BOARD. Assisted Conception (IVF): Review of access criteria. Date of Meeting 21 January 2015 Agenda Item No 13. Title
GOVERNING BOARD Date of Meeting 21 January 2015 Agenda Item No 13 Title Assisted Conception (IVF): Review of access criteria Purpose of Paper The SHIP (Southampton, Hampshire, Isle of Wight and Portsmouth)
More informationUnderstanding IVF Processes in Surrogacy
Melvin H. Thornton II MD Medical Director CT Fertility Understanding IVF Processes in Surrogacy The Basics Surrogacy involves multiple parties IVF CLINIC Egg donors screening and matching* Medical process
More informationLCCG Fertility Services Commissioning Policy
LCCG Fertility Services Commissioning Policy Author: Emma Dwyer & Dr Fiona Sim Version No: V.4 Policy Effective from: 1 st December 2014 Review Date: December 2015 This policy replaces all previous versions.
More informationFertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.
Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art
More informationCOMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.
COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.3 2017 Agreed at Cannock Chase CCG Signature: Designation: Chair of
More informationDRAFT Policy for Assisted Conception
NHS Birmingham and Solihull Clinical Commissioning Group NHS Sandwell and West Birmingham Clinical Commissioning Group DRAFT Policy for Assisted Conception 1 Document Details: Version: DRAFT v7. Ratified
More informationNote: This updated policy supersedes all previous fertility policies and reflects changes agreed by BHR CCGs governing bodies in June 2017.
Fertility Policy 10 July 2017 Note: This updated policy supersedes all previous fertility policies and reflects changes agreed by BHR CCGs governing bodies in June 2017. Introduction BHR CCGs are responsible
More informationFertility Services Commissioning Policy (Level 3)
Fertility Services Commissioning Policy (Level 3) Author: Karin Bryant (Norwich CCG) has coordinated the refresh of policy Version No: V54 Policy Effective from: TBC Review Date: TBC This policy replaces
More informationThe study of correlation between BMI and infertility. Dr. seyed mohammadreza fouladi
The study of correlation between BMI and infertility Dr. seyed mohammadreza fouladi Female Infertility Infertility is a generally defined as one year unprotected intercourse without contraception. Approximately
More informationSCIENTIFIC STUDY REPORT
PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established
More informationFertility treatment and referral criteria for tertiary level assisted conception
Fertility treatment and referral criteria for tertiary level assisted conception Version Number 2.0 Ratified by HVCCG Exec Team Date Ratified 9 th November 2017 Name of Originator/Author Dr Raj Nagaraj
More informationLEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME
LEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME Diana A. Chirinos, Ronald Goldberg, Elias Querales-Mago, Miriam Gutt, Judith R. McCalla, Marc Gellman and Neil Schneiderman
More informationThe New England Journal of Medicine
The New England Journal of Medicine Copyright, 1998, by the Massachusetts Medical Society VOLUME 9 A UGUST 7, 1998 NUMBER 9 REDUCING THE RISK OF MULTIPLE BIRTHS BY TRANSFER OF TWO EMBRYOS AFTER IN VITRO
More informationMaternal and Infant Nutrition Briefs
Maternal and Infant Nutrition Briefs A research-based newsletter prepared by the University of California for professionals interested in maternal and infant nutrition March/April 2003 New Guidelines on
More informationprogramme. The DE-PLAN follow up.
What are the long term results and determinants of outcomes in primary health care diabetes prevention programme. The DE-PLAN follow up. Aleksandra Gilis-Januszewska, Noël C Barengo, Jaana Lindström, Ewa
More informationIVF. NHS North West London CCGs
IVF NHS North West London CCGs Commissioning Policy for In Vitro Fertilisation (IVF)/ Intracytoplasmic Sperm Injection (ICSI) within tertiary Infertility Services Adopted by NWL CCGs to be effective from
More informationDoes a woman s educational attainment influence in vitro fertilization outcomes?
Does a woman s educational attainment influence in vitro fertilization outcomes? The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.
More informationApplication of OMICS technologies on Gamete and Embryo Selection
Application of OMICS technologies on Gamete and Embryo Selection Denny Sakkas, Ph.D. Scientific Director, Boston IVF Waltham, MA, USA THE FUTURE ROLE OF THE EMBRYOLOGIST WILL FOCUS ON PROVIDING OUR PATIENTS
More informationAre all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes?
Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes? Andrea Weghofer Foundation for Reproductive Medicine 2017 New York, November 16-19 Conflict of interest No relevant financial
More informationAutologous Mitochondria Injection to Improve Oocyte Function in Women Undergoing IVF. Robert Casper MD University of Toronto and TRIO Fertility
Autologous Mitochondria Injection to Improve Oocyte Function in Women Undergoing IVF Robert Casper MD University of Toronto and TRIO Fertility Disclosures Member of Scientific Advisory Board of OvaScience
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationSocioeconomic inequalities in lipid and glucose metabolism in early childhood
10 Socioeconomic inequalities in lipid and glucose metabolism in early childhood Gerrit van den Berg, Manon van Eijsden, Francisca Galindo-Garre, Tanja G.M. Vrijkotte, Reinoud J.B.J. Gemke BMC Public Health
More informationWhat is polycystic ovary syndrome? What are polycystic ovaries? What are the symptoms of PCOS?
What is polycystic ovary syndrome? Polycystic ovary syndrome (PCOS) is a condition which can affect a woman s menstrual cycle, fertility, hormones and aspects of her appearance. It can also affect your
More informationSHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs)
SHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs) Policy Recommendation 002: Assisted Conception Services Date of Issue: September 2014
More informationUnderstanding the metabolic syndrome
Understanding the metabolic syndrome Understanding the metabolic system Metabolic syndrome is the clustering together of a number of risk factors for heart disease, stroke and diabetes. Having one of these
More informationModifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health
Modifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health Robert Clarke Clinical Trial Service Unit University of Oxford 28 th May
More informationHonorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.
Prof.Duru Shah Founder President The PCOS Society (India) President Elect of the Indian Society for Assisted Reproduction (ISAR) Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive
More informationAbout PCOS. About PCOS
About PCOS About PCOS Polycystic Ovarian Syndrome (PCOS) is the most common hormonal reproductive problem in women of childbearing age. It can affect a woman s menstrual cycle, fertility, hormones, insulin
More informationHold On To Your Dreams
Hold On To Your Dreams Dr. Michael Kettel Dr. Sandy Chuan 1. THE BASICS OF IVF & EMBRYO DEVELOPMENT 2. IVF ADD-ONS - MYTH VS. SCIENCE IN VITRO FERTILIZATION 1. Ovarian Stimulation 2. Egg Retrieval 3. Create
More informationNorth Staffordshire Clinical Commissioning Group. Infertility and Assisted Reproduction Commissioning Policy and Eligibility Criteria
North Staffordshire Clinical Commissioning Group Infertility and Assisted Reproduction Commissioning Policy and Eligibility Criteria Policy Infertility and Assisted Reproduction Commissioning Policy and
More information